We can't find the internet
Attempting to reconnect
15523.1 PFLS-LS
Preparation of enantiopure antimalarial agent (+)-mefloquine
Zusammenfassung
Preparation of enantiopure antimalarial agent (+)-mefloquine
Weitere Texte
Abstract
Chiral amines are key components of pharmaceuticals but can be difficult, enviornmentally unfriendly, and|expensive to prepare. An excellent example of this problem is mefloquine, an anti-malerial drug currently|available only as a racemic mixture despite the fact that the (+)-enantiomer exhibits the desired activity while the side effects are associated with the (-)-enantiomer. This project will develop a new technology for separating the enantiomers of chiral amines from their mixtures on a kilogram scale. Working with Roche, this technology will be scaled up and used to prepare several hundred grams of enantiopure (+)-mefloquine, a quantity sufficient for early stage clinical trials.
Beteiligte
Alec Fettes
Wirtschaftspartner
alec.fettes@roche.com
F. Hoffmann-La Roche Ltd CHE-105.815.381 Alec Fettes Building 65/618 / Grenzacherstrasse 124 4070 Basel BS CH
Jeffrey Bode
Kontaktperson
bode@org.chem.ethz.ch
ETH Zürich Jeffrey Bode Wolfgang-Pauli-Strasse 10 8093 Zürich ZH CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2013-11-30
- Enddatum
- 2015-11-30
- Bewilligte Gesamtkosten
- CHF 294310.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T490 Biotechnology 100.0%